Simulation of pool testing strategies to identify patients with COVID-19

June 23, 2020

What The Study Did: The feasibility of using pool testing to identify patients with COVID-19 in a setting with limited testing availability was examined in this decision analytical model study.

Authors: Alhaji Cherif, Ph.D., of the Renal Research Institute in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.13075)

Editor's Note: The article includes conflicts of interest disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
-end-
Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.13075?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062320

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Related Additional Information Articles from Brightsurf:

Patients at risk of atrial fibrillation may need additional monitoring after heart surgery
There appears to be a high rate of unrecognized atrial fibrillation in the month following heart surgery among people who have an increased risk of stroke, even when atrial fibrillation was not detected immediately following surgery.

Study provides additional support for use of new class of diabetes drugs
A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels.

0.5°C of additional warming has a huge effect on global aridity
In a simulation study, UTokyo researchers showed that limiting global warming to 1.5°C rather than 2°C will mitigate aridification in some regions of the world including the Mediterranean, western Europe, and southern Africa.

COVID-19 patients with sleep apnoea could be at additional risk
People who have been diagnosed with obstructive sleep apnoea could be at increased risk of adverse outcomes from COVID-19 according to a new study from the University of Warwick.

Additional data on blood thinner efficacy for COVID-19 and insight on best possible regimens
Mount Sinai study is the basis of a new international clinical trial.

Doctors motivated by both health, malpractice concerns when ordering additional tests
A UCLA-led study has found that dermatopathologists, who specialize in diagnosing skin diseases at the microscopic level, are motivated both by patient safety concerns and by malpractice fears -- often simultaneously -- when ordering multiple tests and obtaining second opinions, with a higher proportion of these doctors reporting patient safety as a concern.

Additional genetic cause for non-alcoholic fatty liver disease discovered
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in Europe and the United States.

HPV vaccine hesitancy in Japan could result in 5,000 additional death
The precipitous drop in HPV vaccination rates after suspension of proactive recommendations by the government in 2013 could result in an additional 25,000 cervical cancer cases and more than 5,000 additional deaths among females born between 1994 to 2007 in Japan.

Study shows risks for additional procedures after bariatric surgery
Which of the two most common bariatric surgeries -- gastric sleeve or gastric bypass -- has the highest subsequent risk of additional operations or procedures?

An additional component can triple vaccine efficiency, and scientists explained how
A team of Russian scientists carried out a study on the cell immunity level and found out how an adjuvant called azoximer bromide increases the immunogenicity of the anti-flu vaccine.

Read More: Additional Information News and Additional Information Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.